Survey Study for Velaglucerase Alfa (VPRIV) in Japan

التفاصيل البيبلوغرافية
العنوان: Survey Study for Velaglucerase Alfa (VPRIV) in Japan
المصدر: VPRIV Drug Use-Result Survey (Japan)
Sagara R, Ishigaki M, Otsuka M, Murayama K, Ida H, Fernandez J. Long-term safety and effectiveness of velaglucerase alfa in Gaucher disease: 6-year interim analysis of a post-marketing surveillance in Japan. Orphanet J Rare Dis. 2021 Dec 4;16(1):502. doi: 10.1186/s13023-021-02119-2.
Other URLs: https://vivli.org/ourmember/takeda/
قاعدة البيانات: ClinicalTrials.gov